Ontology highlight
ABSTRACT:
PROVIDER: PRJNA260717 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Escherichia coli producing New Delhi metallo-beta-lactamase (NDM)
| PRJNA399755 | ENA
Project description:A novel new metallo-beta-lactamase gene: NDM-likelihood gene.
| PRJNA497246 | ENA
Project description:Metallo-beta-lactamase-encoding plasmids from Pseudomonas spp. clinical isolates
| PRJNA527981 | ENA
Project description:Dissemination of NDM-1 metallo- β-lactamase in Acinetobacter spp. in Argentina
| PRJNA562922 | ENA
Project description:Escherichia coli and Klebsiella pneumoniae isolates which produce a New Delhi Metallo-beta-lactamase (NDM)
| PRJNA328507 | ENA
Project description:IMP-type Metallo-beta-lactamase-producing Klebsiella pneumoniae WGS
| PRJDB8047 | ENA
Project description:The <i>C. elegans</i> gene swip-10 encodes an orphan metallo beta-lactamase that genetic studies indicate is vital for limiting neuronal excitability and viability. Sequence analysis indicates that the mammalian gene Mblac1 is the likely ortholog of swip-10, with greatest sequence identity localized to the encoded protein's single metallo beta-lactamase domain. The substrate for the SWIP-10 protein remains unknown and to date no functional roles have been ascribed to MBLAC1, though we have shown that the protein binds the neuroprotective beta-lactam antibiotic, ceftriaxone. To gain insight into the functional role of MBLAC1 in vivo, we used CRISPR/Cas9 methods to disrupt N-terminal coding sequences of the mouse Mblac1 gene, resulting in a complete loss of protein expression in viable, homozygous knockout (KO) animals. Using serum from both WT and KO mice, we performed global, untargeted metabolomic analyses, resolving small molecules via hydrophilic interaction chromatography (HILIC) based ultra-performance liquid chromatography, coupled to mass spectrometry (UPLC-MS/MS). Unsupervised principal component analysis reliably segregated the metabolomes of MBLAC1 KO and WT mice, with 92 features subsequently nominated as significantly different by ANOVA, and for which we made tentative and putative metabolite assignments. Bioinformatic analyses of these molecules nominate validated pathways subserving bile acid biosynthesis and linoleate metabolism, networks known to be responsive to metabolic and oxidative stress. Our findings lead to hypotheses that can guide future targeted studies seeking to identify the substrate for MBLAC1 and how substrate hydrolysis supports the neuroprotective actions of ceftriaxone.<br>
2019-03-12 | MTBLS650 | MetaboLights
Project description:A transferrable IncL/M plasmid harboring IMP-1 metallo-beta-lactamase
| PRJDB11945 | ENA